Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical ...
(BHVN) closed 7% higher on Wednesday on the heels of hitting enrollment milestones in two high-priority clinical programs, ...
Investigator & Co-Director of the Neurotherapeutics IWI, Lundquist Institute (Formerly "LA BioMed"); Assistant Professor, David Geffen School of Medicine at UCLA Department of Neurology Ataxia ...
Webcast on Monday, June 29, 2026, at 7:45 am ET BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc ...
Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...
Drivers have been told that if they do not act correctly, they could face serious consequences ...
Detailed price information for Lexeo Therapeutics Inc (LXEO-Q) from The Globe and Mail including charting and trades.
A little-known, rarely described condition, pseudologia fantastica, could be more prevalent and influential than anyone ...
Joubert syndrome (JS) is a rare ciliopathy characterised by the molar tooth sign on brain MRI, cerebellar vermis hypoplasia, hypotonia and developmental delay. We report an elementary school-aged boy ...
Eimear McAndrew was diagnosed with early-onset Spinocerebellar Ataxia 7 (SCA7) at 27 years old, which is an aggressive ...
Larimar Therapeutics Inc. LRMR said Monday it has submitted the first module of a rolling Biologics License Application to ...
The Maine Center for Disease Control and Prevention on Tuesday confirmed the state’s first case of Powassan virus this year. The disease was detected in a Penobscot County resident who was infected in ...